跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLICLAZIDE MR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GLICLAZIDE MR
Authorized
STANDARD
GLICLAZIDE MR
sanis health inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
43a4f37f093d6269
Company
sanis health inc
Type
Standard
Approval Details
Approval Id
43a4f37f093d6269
Drug Approval Canada Name
GLICLAZIDE MR
Product Name
GLICLAZIDE MR
Status
Dormant
Status Date
2025-05-15
Original Market Date
2022-07-08
Din
02524864
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.20
Atc Original
A10BB09 GLICLAZIDE
Atc Name
a 10 bb 09
Aig Number
0119934003
Company Name
sanis health inc
Company Address
1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5
Active Ingredients
GLICLAZIDE
60 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
43a4f37f093d6269
Type
Standard
Back to Health Canada Approvals